home / stock / apvo / apvo news


APVO News and Press, Aptevo Therapeutics Inc. From 06/14/24

Stock Information

Company Name: Aptevo Therapeutics Inc.
Stock Symbol: APVO
Market: NASDAQ
Website: aptevotherapeutics.com

Menu

APVO APVO Quote APVO Short APVO News APVO Articles APVO Message Board
Get APVO Alerts

News, Short Squeeze, Breakout and More Instantly...

APVO - Aptevo Therapeutics files to sell 6.02M shares of common stock

2024-06-14 16:43:31 ET More on Aptevo Therapeutics Seeking Alpha’s Quant Rating on Aptevo Therapeutics Historical earnings data for Aptevo Therapeutics Financial information for Aptevo Therapeutics Read the full article on Seeking Alpha For fur...

APVO - Aptevo Participating in the BIO International Convention

SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immuno-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced that the Comp...

APVO - Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA

Lecture to focus on engineering strategies applied to design safe and efficacious bispecific drug candidates, utilizing our proprietary platform technologies SEATTLE, WA / ACCESSWIRE / May 14, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on ...

APVO - Aptevo Therapeutics GAAP EPS of -$9.95 beats by $2.90

2024-05-08 11:25:32 ET More on Aptevo Therapeutics Seeking Alpha’s Quant Rating on Aptevo Therapeutics Historical earnings data for Aptevo Therapeutics Financial information for Aptevo Therapeutics Read the full article on Seeking Alpha For fur...

APVO - Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update

Heavily pre-treated breast cancer patient who achieved stable disease on study, remains on treatment for more than eleven months after entering the ALG.APV-527 Phase 1 trial with progressive disease and transitioning to higher dose with potential for greater clinical benefit, experienced no new a...

APVO - AEON, SGBX and APVO among pre-market losers

2024-05-03 08:36:49 ET More on pre-market losers & stocks. Safe & Green signs deal for design and production of eight units, currently in concept stage Seeking Alpha’s Quant Rating on AEON Biopharma, Inc. Historical earnings data for AEON Biopharma, In...

APVO - US Companies Moving the Markets, Morning edition
Thu, May 02, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Allarity Therapeutics Inc. (ALLR) rose 97.8% to $2.71 on volume of 44,141,232 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 1.1% to $0.0456 on volume of 28,670,184 shares Emergent Biosolutions Inc. (EBS) rose 67.7% to $3...

APVO - US Companies Moving the Markets, Evening edition
Wed, May 01, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 2.3% to $12.22 on volume of 208,602,591 shares CytomX Therapeutics Inc. (CTMX) rose 214.7% to $5.13 on volume of 203,288,355 shares Akanda Corp. (AKAN) rose 25.4% to $0.1166 on volume of 179,349,234 shares ...

APVO - Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering

SEATTLE, WA / ACCESSWIRE / April 15, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing...

APVO - US Companies Moving the Markets, Evening edition
Thu, Apr 11, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Nikola Corporation (NKLA) fell 26.7% to $0.717 on volume of 293,193,103 shares PROSHARES TRUST (SQQQ) fell 4.6% to $10.4 on volume of 158,399,098 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.4% to $3.21 on volume o...

Previous 10 Next 10